ID   KS6A3_HUMAN             Reviewed;         740 AA.
AC   P51812; B2R9V4; Q4VAP3; Q59H26; Q5JPK8; Q7Z3Z7;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   02-NOV-2010, entry version 111.
DE   RecName: Full=Ribosomal protein S6 kinase alpha-3;
DE            Short=S6K-alpha-3;
DE            EC=2.7.11.1;
DE   AltName: Full=90 kDa ribosomal protein S6 kinase 3;
DE            Short=p90-RSK 3;
DE            Short=p90RSK3;
DE   AltName: Full=Insulin-stimulated protein kinase 1;
DE            Short=ISPK-1;
DE   AltName: Full=MAP kinase-activated protein kinase 1b;
DE            Short=MAPK-activated protein kinase 1b;
DE            Short=MAPKAP kinase 1b;
DE            Short=MAPKAPK-1b;
DE   AltName: Full=Ribosomal S6 kinase 2;
DE            Short=RSK-2;
DE   AltName: Full=pp90RSK2;
GN   Name=RPS6KA3; Synonyms=ISPK1, MAPKAPK1B, RSK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta, and T-cell;
RX   MEDLINE=95113220; PubMed=7813820;
RA   Bjoerbaek C., Vik T.A., Echwald S.M., Webb G.C., Wang J.P.,
RA   Yang P.-Y., Vestergaard H., Richmond K., Hansen T., Erikson R.L.,
RA   Miklos G.L.G., Cohen P.T.W., Pedersen O.;
RT   "Cloning of a human insulin-stimulated protein kinase (ISPK-1) gene
RT   and analysis of coding regions and mRNA levels of the ISPK-1 and the
RT   protein phosphatase-1 genes in muscle from NIDDM patients.";
RL   Diabetes 44:90-97(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2-582.
RC   TISSUE=Skeletal muscle;
RX   MEDLINE=94189676; PubMed=8141249;
RA   Moller D.E., Xia C.-H., Tang W., Zhu A.X., Jakubowski M.;
RT   "Human rsk isoforms: cloning and characterization of tissue-specific
RT   expression.";
RL   Am. J. Physiol. 266:C351-C359(1994).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 15-735.
RX   MEDLINE=22763540; PubMed=12777533; DOI=10.1093/molbev/msg134;
RA   Kitano T., Schwarz C., Nickel B., Paeaebo S.;
RT   "Gene diversity patterns at 10 X-chromosomal loci in humans and
RT   chimpanzees.";
RL   Mol. Biol. Evol. 20:1281-1289(2003).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-365 AND SER-369, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-715, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [10]
RP   INTERACTION WITH NFATC4.
RX   PubMed=17213202; DOI=10.1074/jbc.M611322200;
RA   Cho Y.-Y., Yao K., Bode A.M., Bergen H.R. III, Madden B.J., Oh S.-M.,
RA   Ermakova S., Kang B.S., Choi H.S., Shim J.-H., Dong Z.;
RT   "RSK2 mediates muscle cell differentiation through regulation of
RT   NFAT3.";
RL   J. Biol. Chem. 282:8380-8392(2007).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-715, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-227; THR-231; THR-365;
RP   SER-369 AND SER-715, AND MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-715, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=19007248; DOI=10.1021/ac801708p;
RA   Wang B., Malik R., Nigg E.A., Korner R.;
RT   "Evaluation of the low-specificity protease elastase for large-scale
RT   phosphoproteome analysis.";
RL   Anal. Chem. 80:9526-9533(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-227; THR-365; SER-369;
RP   SER-375; SER-386; SER-415; SER-556 AND SER-715, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-365; SER-369; SER-375
RP   AND SER-715, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17; SER-19; TYR-226;
RP   SER-227; THR-365; SER-369; SER-375; SER-386; THR-391; SER-415; SER-715
RP   AND SER-737, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-415 AND SER-715, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [19]
RP   VARIANTS CLS VAL-75 AND ALA-227.
RX   MEDLINE=97113410; PubMed=8955270; DOI=10.1038/384567a0;
RA   Trivier E., de Cesare D., Jacquot S., Pannetier S., Zackai E.,
RA   Young I., Mandel J.-L., Sassone-Corsi P., Hanauer A.;
RT   "Mutations in the kinase Rsk-2 associated with Coffin-Lowry
RT   syndrome.";
RL   Nature 384:567-570(1996).
RN   [20]
RP   VARIANTS CLS PHE-82; GLN-127; TYR-154; VAL-225 AND ASP-431, AND
RP   VARIANT SER-38.
RX   MEDLINE=99057500; PubMed=9837815; DOI=10.1086/302153;
RA   Jacquot S., Merienne K., de Cesare D., Pannetier S., Mandel J.-L.,
RA   Sassone-Corsi P., Hanauer A.;
RT   "Mutation analysis of the RSK2 gene in Coffin-Lowry patients:
RT   extensive allelic heterogeneity and a high rate of De novo
RT   mutations.";
RL   Am. J. Hum. Genet. 63:1631-1640(1998).
RN   [21]
RP   VARIANTS CLS TRP-114 AND GLN-729.
RX   MEDLINE=99191975; PubMed=10094187; DOI=10.1038/sj.ejhg.5200231;
RA   Abidi F., Jacquot S., Lassiter C., Trivier E., Hanauer A.,
RA   Schwartz C.E.;
RT   "Novel mutations in Rsk-2, the gene for Coffin-Lowry syndrome (CLS).";
RL   Eur. J. Hum. Genet. 7:20-26(1999).
RN   [22]
RP   VARIANT [LARGE SCALE ANALYSIS] VAL-416.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [23]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-38; CYS-483; PHE-608 AND CYS-723.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine kinase that may play a role in
CC       mediating the growth-factor and stress induced activation of the
CC       transcription factor CREB.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium (By similarity).
CC   -!- ENZYME REGULATION: Activated by multiple phosphorylations on
CC       threonine and serine residues (By similarity).
CC   -!- SUBUNIT: Forms a complex with either ERK1 or ERK2 in quiescent
CC       cells. Transiently dissociates following mitogenic stimulation (By
CC       similarity). Interacts with NFATC4.
CC   -!- TISSUE SPECIFICITY: Expressed in many tissues, highest levels in
CC       skeletal muscle.
CC   -!- PTM: Autophosphorylated on Ser-386, as part of the activation
CC       process (By similarity).
CC   -!- PTM: Ser-227 phosphorylation promotes Ser-386 phosphorylation and
CC       leads to basal activation. Full activation by growth factors
CC       requires additional phosphorylation on Ser-369 (By similarity).
CC   -!- DISEASE: Defects in RPS6KA3 are the cause of Coffin-Lowry syndrome
CC       (CLS) [MIM:303600]; an X-linked dominant disorder characterized by
CC       severe mental retardation with facial and digital dysmorphisms,
CC       and progressive skeletal deformations.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. S6 kinase subfamily.
CC   -!- SIMILARITY: Contains 1 AGC-kinase C-terminal domain.
CC   -!- SIMILARITY: Contains 2 protein kinase domains.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92170.1; Type=Erroneous initiation;
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/RPS6KA3";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U08316; AAA81952.1; -; mRNA.
DR   EMBL; AK313932; BAG36651.1; -; mRNA.
DR   EMBL; AB208933; BAD92170.1; ALT_INIT; mRNA.
DR   EMBL; AL732366; CAI40548.1; -; Genomic_DNA.
DR   EMBL; AL807772; CAI40548.1; JOINED; Genomic_DNA.
DR   EMBL; AL807772; CAI39687.1; -; Genomic_DNA.
DR   EMBL; AL732366; CAI39687.1; JOINED; Genomic_DNA.
DR   EMBL; BC096301; AAH96301.1; -; mRNA.
DR   EMBL; BC096302; AAH96302.1; -; mRNA.
DR   EMBL; BC096303; AAH96303.1; -; mRNA.
DR   EMBL; L07599; AAC82495.1; -; mRNA.
DR   EMBL; AB102662; BAC81131.1; -; mRNA.
DR   IPI; IPI00020898; -.
DR   PIR; I38556; I38556.
DR   RefSeq; NP_004577.1; -.
DR   UniGene; Hs.445387; -.
DR   ProteinModelPortal; P51812; -.
DR   SMR; P51812; 59-346, 66-389, 417-714.
DR   DIP; DIP-38247N; -.
DR   IntAct; P51812; 7.
DR   MINT; MINT-1542962; -.
DR   STRING; P51812; -.
DR   PhosphoSite; P51812; -.
DR   PeptideAtlas; P51812; -.
DR   PRIDE; P51812; -.
DR   Ensembl; ENST00000379565; ENSP00000368884; ENSG00000177189.
DR   GeneID; 6197; -.
DR   KEGG; hsa:6197; -.
DR   UCSC; uc004czu.1; human.
DR   CTD; 6197; -.
DR   GeneCards; GC0XM020168; -.
DR   H-InvDB; HIX0016692; -.
DR   HGNC; HGNC:10432; RPS6KA3.
DR   HPA; CAB003853; -.
DR   HPA; CAB013520; -.
DR   HPA; HPA003221; -.
DR   MIM; 300075; gene.
DR   MIM; 303600; phenotype.
DR   Orphanet; 192; Coffin-Lowry syndrome.
DR   Orphanet; 777; X-linked nonsyndromic intellectual deficit.
DR   PharmGKB; PA34847; -.
DR   eggNOG; prNOG07944; -.
DR   HOGENOM; HBG315633; -.
DR   HOVERGEN; HBG108317; -.
DR   InParanoid; P51812; -.
DR   OMA; RQFELRK; -.
DR   OrthoDB; EOG9V45T5; -.
DR   PhylomeDB; P51812; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Reactome; REACT_11061; Signalling by NGF.
DR   Reactome; REACT_13685; Synaptic Transmission.
DR   Reactome; REACT_18266; Axon guidance.
DR   Reactome; REACT_6900; Signaling in Immune system.
DR   NextBio; 24069; -.
DR   ArrayExpress; P51812; -.
DR   Bgee; P51812; -.
DR   CleanEx; HS_RPS6KA3; -.
DR   Genevestigator; P51812; -.
DR   GermOnline; ENSG00000177189; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; EXP:Reactome.
DR   GO; GO:0007417; P:central nervous system development; TAS:ProtInc.
DR   GO; GO:0007243; P:intracellular protein kinase cascade; IEA:InterPro.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0001501; P:skeletal system development; TAS:ProtInc.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR016239; Ribosomal_S6_kinase_II.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 2.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   PIRSF; PIRSF000606; Ribsml_S6_kin_2; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 2.
DR   SUPFAM; SSF56112; Kinase_like; 2.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 2.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 2.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 2.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Disease mutation; Kinase; Magnesium;
KW   Mental retardation; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Repeat; Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    740       Ribosomal protein S6 kinase alpha-3.
FT                                /FTId=PRO_0000086203.
FT   DOMAIN       68    327       Protein kinase 1.
FT   DOMAIN      328    397       AGC-kinase C-terminal.
FT   DOMAIN      422    679       Protein kinase 2.
FT   NP_BIND      74     82       ATP (By similarity).
FT   NP_BIND     428    436       ATP (By similarity).
FT   ACT_SITE    193    193       Proton acceptor (By similarity).
FT   ACT_SITE    539    539       Proton acceptor (By similarity).
FT   BINDING     100    100       ATP (By similarity).
FT   BINDING     451    451       ATP (By similarity).
FT   MOD_RES      17     17       Phosphoserine.
FT   MOD_RES      19     19       Phosphoserine.
FT   MOD_RES     226    226       Phosphotyrosine.
FT   MOD_RES     227    227       Phosphoserine.
FT   MOD_RES     231    231       Phosphothreonine.
FT   MOD_RES     365    365       Phosphothreonine.
FT   MOD_RES     369    369       Phosphoserine.
FT   MOD_RES     375    375       Phosphoserine.
FT   MOD_RES     386    386       Phosphoserine.
FT   MOD_RES     391    391       Phosphothreonine.
FT   MOD_RES     415    415       Phosphoserine.
FT   MOD_RES     556    556       Phosphoserine.
FT   MOD_RES     577    577       Phosphothreonine (By similarity).
FT   MOD_RES     715    715       Phosphoserine.
FT   MOD_RES     737    737       Phosphoserine.
FT   VARIANT      38     38       I -> S (in dbSNP:rs56218010).
FT                                /FTId=VAR_006188.
FT   VARIANT      75     75       G -> V (in CLS).
FT                                /FTId=VAR_006189.
FT   VARIANT      82     82       V -> F (in CLS).
FT                                /FTId=VAR_006190.
FT   VARIANT     114    114       R -> W (in CLS).
FT                                /FTId=VAR_006191.
FT   VARIANT     127    127       H -> Q (in CLS).
FT                                /FTId=VAR_006192.
FT   VARIANT     154    154       D -> Y (in CLS).
FT                                /FTId=VAR_006193.
FT   VARIANT     225    225       A -> V (in CLS).
FT                                /FTId=VAR_006194.
FT   VARIANT     227    227       S -> A (in CLS).
FT                                /FTId=VAR_006195.
FT   VARIANT     416    416       I -> V (in a breast cancer sample;
FT                                somatic mutation).
FT                                /FTId=VAR_035627.
FT   VARIANT     431    431       G -> D (in CLS).
FT                                /FTId=VAR_006196.
FT   VARIANT     483    483       Y -> C (in a gastric adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040629.
FT   VARIANT     608    608       L -> F (in a glioblastoma multiforme
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040630.
FT   VARIANT     723    723       R -> C (in dbSNP:rs35026425).
FT                                /FTId=VAR_040631.
FT   VARIANT     729    729       R -> Q (in CLS; dbSNP:rs28935171).
FT                                /FTId=VAR_006197.
FT   CONFLICT     89     89       S -> L (in Ref. 5; AAH96303).
FT   CONFLICT    410    410       Missing (in Ref. 3; BAD92170).
FT   CONFLICT    424    424       V -> L (in Ref. 6; AAC82495).
FT   CONFLICT    480    480       K -> N (in Ref. 6; AAC82495).
FT   CONFLICT    494    494       Missing (in Ref. 6; AAC82495).
SQ   SEQUENCE   740 AA;  83736 MW;  486AE8357CEAB6C8 CRC64;
     MPLAQLADPW QKMAVESPSD SAENGQQIMD EPMGEEEINP QTEEVSIKEI AITHHVKEGH
     EKADPSQFEL LKVLGQGSFG KVFLVKKISG SDARQLYAMK VLKKATLKVR DRVRTKMERD
     ILVEVNHPFI VKLHYAFQTE GKLYLILDFL RGGDLFTRLS KEVMFTEEDV KFYLAELALA
     LDHLHSLGII YRDLKPENIL LDEEGHIKLT DFGLSKESID HEKKAYSFCG TVEYMAPEVV
     NRRGHTQSAD WWSFGVLMFE MLTGTLPFQG KDRKETMTMI LKAKLGMPQF LSPEAQSLLR
     MLFKRNPANR LGAGPDGVEE IKRHSFFSTI DWNKLYRREI HPPFKPATGR PEDTFYFDPE
     FTAKTPKDSP GIPPSANAHQ LFRGFSFVAI TSDDESQAMQ TVGVHSIVQQ LHRNSIQFTD
     GYEVKEDIGV GSYSVCKRCI HKATNMEFAV KIIDKSKRDP TEEIEILLRY GQHPNIITLK
     DVYDDGKYVY VVTELMKGGE LLDKILRQKF FSEREASAVL FTITKTVEYL HAQGVVHRDL
     KPSNILYVDE SGNPESIRIC DFGFAKQLRA ENGLLMTPCY TANFVAPEVL KRQGYDAACD
     IWSLGVLLYT MLTGYTPFAN GPDDTPEEIL ARIGSGKFSL SGGYWNSVSD TAKDLVSKML
     HVDPHQRLTA ALVLRHPWIV HWDQLPQYQL NRQDAPHLVK GAMAATYSAL NRNQSPVLEP
     VGRSTLAQRR GIKKITSTAL
//
